248 related articles for article (PubMed ID: 16190566)
1. [Circulatory dysfunction syndrome associated with liver cirrhosis].
Hartleb M
Przegl Epidemiol; 2005; 59(2):549-58. PubMed ID: 16190566
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of portal hypertension.
Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán JC
Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769
[TBL] [Abstract][Full Text] [Related]
3. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
Møller S; Henriksen JH
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
[TBL] [Abstract][Full Text] [Related]
4. Cardiac involvement in liver cirrhosis.
Gatta A; Merkel C; Sacerdoti D; Angeli P
Ann Ital Med Int; 1993; 8(4):244-7. PubMed ID: 8161481
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of ascites in cirrhosis and portal hypertension.
Heneghan MA; Harrison PM
Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
[TBL] [Abstract][Full Text] [Related]
6. [Morphologic and functional abnormalities of the cardiovascular system in patients with hepatic cirrhosis].
Piscione F; Manganiello V; Viola O; Chiariello M
Ital Heart J Suppl; 2003 Feb; 4(2):85-95. PubMed ID: 12762257
[TBL] [Abstract][Full Text] [Related]
7. Portal hypertension: state of the art.
Gatta A; Sacerdoti D; Bolognesi M; Merkel C
Ital J Gastroenterol Hepatol; 1999 May; 31(4):326-45. PubMed ID: 10425579
[TBL] [Abstract][Full Text] [Related]
8. [Liver cirrhosis and cardiovascular system].
Ponte E; Cafagna D
Minerva Med; 1996 Jun; 87(6):299-310. PubMed ID: 8700359
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatment of portal hypertension.
González-Abraldes J; Bosch J; García-Pagán JC
Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
[TBL] [Abstract][Full Text] [Related]
10. Hepatorenal syndrome.
Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
[TBL] [Abstract][Full Text] [Related]
11. [Systemic circulatory hyperkinetic syndrome in patients with cirrhosis. Relation with hepatocellular failure and portal hypertension].
Valla D; Poynard T; Bercoff E; Bataille C; Goldfarb G; Lebrec D
Gastroenterol Clin Biol; 1984 Apr; 8(4):321-4. PubMed ID: 6735039
[TBL] [Abstract][Full Text] [Related]
12. [Natural course and physiopathology of ascites in the cirrhotic patient].
Bernardi M; Colantoni A; Caraceni P; Sica G; Trevisani F
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():30S-38S. PubMed ID: 9004818
[TBL] [Abstract][Full Text] [Related]
13. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
Gatta A; Bolognesi M; Sacerdoti D; Merkel C
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
[TBL] [Abstract][Full Text] [Related]
14. Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.
Bosch J; Pizcueta MP; Fernández M; Feu F; Cirera I; Luca A; García-Pagán JC
Baillieres Clin Gastroenterol; 1992 Sep; 6(3):425-36. PubMed ID: 1421593
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic changes in portal hypertension: new insights in the pathogenesis and clinical implications.
Michielsen PP; Pelckmans PA
Acta Gastroenterol Belg; 1994; 57(2):194-205. PubMed ID: 8053307
[TBL] [Abstract][Full Text] [Related]
16. [Circulatory hyperkinesis of cirrhosis: etiopathogenesis, clinical and therapeutic implications].
Denie C; Henrion J
Acta Gastroenterol Belg; 1993; 56(5-6):338-46. PubMed ID: 7511313
[TBL] [Abstract][Full Text] [Related]
17. Hepatorenal syndrome.
Guevara M; Rodés J
Int J Biochem Cell Biol; 2005 Jan; 37(1):22-6. PubMed ID: 15381144
[TBL] [Abstract][Full Text] [Related]
18. The role of nitric oxide in portal hypertensive systemic and portal vascular pathology.
Hartleb M; Michielsen PP; Dziurkowska-Marek A
Acta Gastroenterol Belg; 1997; 60(3):222-32. PubMed ID: 9396180
[TBL] [Abstract][Full Text] [Related]
19. Arterial hypertension and chronic liver disease.
Henriksen JH; Møller S
Minerva Med; 2005 Aug; 96(4):233-46. PubMed ID: 16179891
[TBL] [Abstract][Full Text] [Related]
20. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.
Hernández-Guerra M; García-Pagán JC; Turnes J; Bellot P; Deulofeu R; Abraldes JG; Bosch J
Hepatology; 2006 Mar; 43(3):485-91. PubMed ID: 16496307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
